ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
129.62
+0.61 (0.47%)
At close: Jul 24, 2025, 4:00 PM
129.19
0.00 (0.00%)
After-hours: Jul 24, 2025, 4:20 PM EDT

ICU Medical Stock Forecast

Stock Price Forecast

The 5 analysts that cover ICU Medical stock have a consensus rating of "Strong Buy" and an average price target of $196.75, which forecasts a 51.79% increase in the stock price over the next year. The lowest target is $187 and the highest is $209.

Price Target: $196.75 (+51.79%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$187$196.75$200$209
Change+44.27%+51.79%+54.30%+61.24%
* Price targets were last updated on May 9, 2025.

Analyst Ratings

The average analyst rating for ICU Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy221222
Buy223222
Hold111111
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Raymond James
Raymond James
Strong Buy
Maintains
$197$187
Strong BuyMaintains$197$187+44.27%May 9, 2025
Keybanc
Keybanc
Buy
Maintains
$209$191
BuyMaintains$209$191+47.35%Apr 21, 2025
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aApr 8, 2025
Jefferies
Jefferies
Strong Buy
Upgrades
$200
Strong BuyUpgrades$200+54.30%Dec 11, 2024
Keybanc
Keybanc
Buy
Maintains
$198$209
BuyMaintains$198$209+61.24%Nov 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
2.25B
from 2.38B
Decreased by -5.59%
Revenue Next Year
2.23B
from 2.25B
Decreased by -0.71%
EPS This Year
6.77
from -4.83
EPS Next Year
8.34
from 6.77
Increased by 23.23%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
1.27B1.32B2.28B2.26B2.38B2.25B2.23B2.36B
Revenue Growth
0.38%3.56%73.21%-0.92%5.44%-5.59%-0.71%5.60%
EPS
4.024.74-3.11-1.23-4.836.778.349.67
EPS Growth
-14.29%17.91%----23.23%15.88%
Forward PE
-----19.1515.5413.41
No. Analysts
-----885
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High2.4B2.4B2.5B
Avg2.2B2.2B2.4B
Low2.1B2.1B2.2B

Revenue Growth

Revenue Growth20252026202720282029
High
0.1%
7.3%
14.1%
Avg
-5.6%
-0.7%
5.6%
Low
-10.7%
-7.0%
-2.4%

EPS Forecast

EPS20252026202720282029
High7.078.8410.45
Avg6.778.349.67
Low6.427.778.98

EPS Growth

EPS Growth20252026202720282029
High-
30.6%
25.2%
Avg-
23.2%
15.9%
Low-
14.8%
7.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.